A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

HG Sprenger, N Langebeek, PGH (Paul) Mulder, CHH Ten Napel, R Vriesendorp, AIM Hoepelman, JC Legrand, PP Koopmans, B Bravenboer, RW Ten Kate, PHP Groeneveld, WFW Bierman, TS Van der Werf, EH Gisolf, C Richter

Research output: Contribution to journalArticleAcademic

4 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)122-131
Number of pages10
JournalHIV Medicine
Issue number2
Publication statusPublished - 2015

Cite this